How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/ccr5-tropic-drug-resistant-hiv-infection.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

CCR5 Tropic Drug Resistant HIV Infection — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CCR5 Tropic Drug Resistant HIV Infection (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating CCR5 Tropic Drug Resistant HIV Infection, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Selzentry	MARAVIROC	GSK	CCR5 Co-receptor Antagonist [EPC]	C-C chemokine receptor type 5		2007-01-01
Selzentry	Selzentry	Icahn School of Medicine at Mount Sinai		Multidrug and toxin extrusion protein 1, C-C chemokine receptor type 5, C-C chemokine receptor type 5

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

GSK · 1 drug in CCR5 Tropic Drug Resistant HIV Infection
Icahn School of Medicine at Mount Sinai · 1 drug in CCR5 Tropic Drug Resistant HIV Infection

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in CCR5 Tropic Drug Resistant HIV Infection:

Cite this brief

Drug Landscape (2026). CCR5 Tropic Drug Resistant HIV Infection — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ccr5-tropic-drug-resistant-hiv-infection. Accessed 2026-06-11.

CCR5 Tropic Drug Resistant HIV Infection full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing